Citadel Advisors
KANG

Citadel Advisors’s iKang Healthcare Group, Inc. KANG Stock Holding History

Citadel Advisors’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21,500
Closed -$440K – 10025
2018
Q2 		$440K Buy
21,500
+6,800
+46% +$137K ﹤0.01% 6583
2018
Q1 		$293K Sell
14,700
-13,600
-48% -$229K ﹤0.01% 6789
2017
Q4 		$447K Sell
28,300
-1,700
-6% -$24.6K ﹤0.01% 5823
2017
Q3 		$404K Buy
30,000
+17,700
+144% +$237K ﹤0.01% 5620
2017
Q2 		$151K Sell
12,300
-52,100
-81% -$755K ﹤0.01% 6734
2017
Q1 		$940K Sell
64,400
-5,600
-8% -$92.1K ﹤0.01% 4096
2016
Q4 		$1.21M Buy
70,000
+43,900
+168% +$743K ﹤0.01% 3598
2016
Q3 		$472K Buy
+26,100
New +$480K ﹤0.01% 4956

Other funds holding KANG

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Conning Inc Hartford, Connecticut $3.34B AUM 25.19% 1-Year Est. Return

Citadel Advisors's KANG Position: Q2 2018 in Review

Citadel Advisors sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2018, closing a stake of 10,944 shares — an estimated $221K sold.

Citadel Advisors first reported a position in KANG in Q3 2014 and held it in 11 quarters. The position peaked at $2.9M in Q4 2016. 63 funds tracked by Wall St. Rank hold KANG as of Q2 2018.

  • Citadel Advisors reported no remaining iKang Healthcare Group, Inc. position as of Q2 2018 after selling out during the quarter.
  • Citadel Advisors sold 10,944 iKang Healthcare Group, Inc. shares in Q2 2018, an estimated $221K.
  • Citadel Advisors first reported a position in iKang Healthcare Group, Inc. in Q3 2014 and held it in 11 quarters.
  • Citadel Advisors's iKang Healthcare Group, Inc. position peaked at $2.9M in Q4 2016.
  • 63 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2018.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.